Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial
      QxMD      Google Scholar   
Citation:
Br J Cancer vol 122 (10) 1453-1460
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
9
Parents:
3073  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                                 
Networks:
 
Study
ALTTO
Multiple Studies, or Legacy Studies in Alliance Study:
NCCTG-N063D
Phases:
3, 3
Keywords:
Breast cancer, Targeted therapies